NATURAL GROCERS BY VITAMIN COTTAGE, INC NGVC
$27.47
-1.36%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $36.00
- Implied Upside
- +31.1%
- Price Target Range
- $36.00 – $36.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-02-13 | Freedom BrokerGeorgy Vashchenko |
Initiates coverage on | Buy | $36 |
| 2020-10-09 | Wolfe Research |
Initiates coverage on | Outperform | $14 |
| 2018-09-18 | CitigroupGreg Badishkanian |
Maintains | Buy | $19 → $20 |
| 2018-08-08 | CitigroupGreg Badishkanian |
Maintains | Buy | $15 → $19 |
| 2018-06-12 | CitigroupGreg Badishkanian |
Maintains | Buy | $11 → $13 |
| 2018-01-31 | RBC Capital |
Upgrades | Sector perform → Outperform | — |
| 2017-11-17 | Deutsche BankShane Higgins |
Maintains | Hold | $8 → $6 |
| 2017-08-14 | CitigroupGreg Badishkanian |
Maintains | Buy | $11 → $8 |
| 2017-02-03 | SunTrust Robinson Humphrey |
Downgrades | Buy → Hold | — |
| 2017-01-31 | JefferiesChristopher Sighinolfi |
Downgrades | Buy → Hold | — |
| 2016-10-11 | CitigroupGreg Badishkanian |
Initiates coverage on | Buy | — |
| 2016-09-30 | JefferiesChristopher Sighinolfi |
Maintains | Buy | $19 → $15 |
| 2016-09-23 | Barclays |
Initiates coverage on | Equal-weight | $12 |
| 2016-05-19 | JefferiesChristopher Sighinolfi |
Maintains | Buy | $21 → $19 |
| 2016-04-21 | RBC Capital |
Downgrades | Outperform → Sector perform | — |
| 2016-02-10 | Deutsche BankShane Higgins |
Initiates coverage on | Hold | $20 |
| 2015-11-20 | SunTrust Robinson Humphrey |
Maintains | Buy | $35 → $30 |
| 2015-08-26 | JefferiesChristopher Sighinolfi |
Initiates coverage on | Buy | $31 |
| 2015-08-04 | Wedbush |
Upgrades | Underperform → Neutral | $22 → $24 |
| 2015-06-05 | Stephens & Co. |
Upgrades | Equal-weight → Overweight | — |
| 2015-01-23 | Piper Sandler |
Upgrades | Neutral → Overweight | $21 → $34 |
| 2014-12-01 | Stephens & Co. |
Upgrades | Equal-weight → Overweight | $24 → $29 |
| 2014-10-13 | Oppenheimer |
Maintains | Perform | $22 → $15 |
| 2014-08-28 | Wedbush |
Initiates coverage on | Neutral | $19 |
| 2014-08-04 | Stephens & Co. |
Downgrades | Overweight → Equal-weight | $42 → $23 |
| 2014-05-21 | Piper Sandler |
Downgrades | Overweight → Neutral | $37 → $22 |
| 2014-05-05 | Imperial Capital |
Upgrades | In-line → Outperform | $35 |
| 2013-12-19 | Imperial Capital |
Initiates coverage on | In-line | $40 |
| 2013-09-09 | Wells Fargo |
Initiates coverage on | Outperform | — |
| 2013-04-30 | Longbow Research |
Initiates coverage on | Neutral | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $27.47
- Market Cap
- $633.07 million
- 52-Week Range
- $23.47 – $45.98
- Average Volume
- 142K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.